C. Chou to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications C. Chou has written about Xenograft Model Antitumor Assays.
Connection Strength
0.129
-
Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia. Mol Cancer Ther. 2008 Apr; 7(4):769-78.
Score: 0.072
-
Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor. J Med Chem. 2015 May 28; 58(10):4325-38.
Score: 0.030
-
Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity. J Med Chem. 2014 Apr 24; 57(8):3324-41.
Score: 0.027